HCP

FDA-Approved, Clinically Proven Solution for Stress Urinary Incontinence

INNOVO is Medicare Eligible

Contact our partners at Current Medical Technologies, Inc. for more details.

Introducing INNOVO

INNOVO is an FDA-approved, clinically proven, non-invasive, user-preferred therapy to treat Stress Urinary Incontinence, a life-limiting condition that impacts more than 1 in 3 women in the US.

INNOVO uses neuromuscular electrical stimulation (NMES) to activate and strengthen the pelvic floor muscles, providing 180 Kegel contractions in each 30 minute therapy session.

Clinical trials of INNOVO conducted with over 600 research participants consistently confirm improvements in key outcomes, symptoms, and acceptability.

This ultrasound visualisation shows INNOVO in action – physically contracting and relaxing the pelvic floor muscles.

Why Clinicians Recommend INNOVO?

Non-invasive: unlike other pelvic floor devices, INNOVO is completely non-invasive, activating the pelvic floor muscles using a pair of body-worn shorts.

Effective: with over 6 million therapy sessions delivered, it’s a user-preferred solution that truly works.

FDA-Approved: INNOVO is approved by the FDA and clinically proven to treat pelvic floor weakness, the primary cause of stress urinary incontinence. In our clinical studies, 87% of women were dry or nearly dry after using INNOVO for 12 weeks.

INNOVO is Medicare Eligible Convenient & Safe: INNOVO lets patient exercise their pelvic floor effectively in the comfort of their own home.

To find out more about how to incorporate INNOVO into your SUI (stress urinary incontinence) care pathway, please contact our partners at Current Medical Technologies Inc.

Shop Innovo

Additional Resources

Item added to your cart

People Who Bought INNOVO Kit Also Bought